rs61746524

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020442.6(VARS2):​c.1514C>T​(p.Ser505Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00235 in 1,613,870 control chromosomes in the GnomAD database, including 96 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 52 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 44 hom. )

Consequence

VARS2
NM_020442.6 missense

Scores

8
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.19

Publications

1 publications found
Variant links:
Genes affected
VARS2 (HGNC:21642): (valyl-tRNA synthetase 2, mitochondrial) This gene encodes a mitochondrial aminoacyl-tRNA synthetase, which catalyzes the attachment of valine to tRNA(Val) for mitochondrial translation. Mutations in this gene cause combined oxidative phosphorylation deficiency-20, and are also associated with early-onset mitochondrial encephalopathies. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2014]
VARS2 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • combined oxidative phosphorylation defect type 20
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0051003397).
BP6
Variant 6-30921099-C-T is Benign according to our data. Variant chr6-30921099-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 381460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0129 (1965/152266) while in subpopulation AFR AF = 0.0449 (1866/41524). AF 95% confidence interval is 0.0432. There are 52 homozygotes in GnomAd4. There are 859 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 52 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VARS2NM_020442.6 linkc.1514C>T p.Ser505Phe missense_variant Exon 16 of 30 ENST00000676266.1 NP_065175.4 Q5ST30-1B4E0K6B4DG77
VARS2NM_001167734.2 linkc.1604C>T p.Ser535Phe missense_variant Exon 16 of 30 NP_001161206.1 Q5ST30-4A0A1U9X9B3
VARS2NM_001167733.3 linkc.1094C>T p.Ser365Phe missense_variant Exon 15 of 29 NP_001161205.1 Q5ST30-3B4E0K6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VARS2ENST00000676266.1 linkc.1514C>T p.Ser505Phe missense_variant Exon 16 of 30 NM_020442.6 ENSP00000502585.1 Q5ST30-1

Frequencies

GnomAD3 genomes
AF:
0.0129
AC:
1961
AN:
152148
Hom.:
52
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0450
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00329
AC:
827
AN:
251056
AF XY:
0.00226
show subpopulations
Gnomad AFR exome
AF:
0.0440
Gnomad AMR exome
AF:
0.00246
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.000980
GnomAD4 exome
AF:
0.00125
AC:
1823
AN:
1461604
Hom.:
44
Cov.:
33
AF XY:
0.00100
AC XY:
727
AN XY:
727104
show subpopulations
African (AFR)
AF:
0.0424
AC:
1421
AN:
33476
American (AMR)
AF:
0.00295
AC:
132
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26102
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000863
AC:
96
AN:
1111862
Other (OTH)
AF:
0.00267
AC:
161
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
102
204
305
407
509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0129
AC:
1965
AN:
152266
Hom.:
52
Cov.:
32
AF XY:
0.0115
AC XY:
859
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0449
AC:
1866
AN:
41524
American (AMR)
AF:
0.00431
AC:
66
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68028
Other (OTH)
AF:
0.00805
AC:
17
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
89
179
268
358
447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00532
Hom.:
33
Bravo
AF:
0.0147
ESP6500AA
AF:
0.0399
AC:
176
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00395
AC:
480
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 19, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 15, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.43
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.041
T;.;.
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.54
T;T;T
MetaRNN
Benign
0.0051
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M;.;.
PhyloP100
2.2
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-3.3
D;.;D
REVEL
Benign
0.096
Sift
Uncertain
0.0090
D;.;D
Sift4G
Uncertain
0.028
D;D;D
Polyphen
0.91
P;.;.
Vest4
0.34
MVP
0.62
MPC
0.88
ClinPred
0.027
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.14
gMVP
0.49
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61746524; hg19: chr6-30888876; API